[Undesirable effects of hypolipemic drugs].
D000328:Adult; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001361:Avitaminosis / Q000139:chemically induced; D001660:Biliary Tract Diseases / Q000139:chemically induced; D002792:Cholestyramine Resin / Q000009:adverse effects; D002994:Clofibrate / Q000009:adverse effects; D003327:Coronary Disease / Q000517:prevention & control; D003918:Dextrothyroxine / Q000009:adverse effects; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006073:Gout / Q000139:chemically induced; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000009:adverse effects; D010743:Phospholipids / Q000009:adverse effects; D011727:Pyridinolcarbamate / Q000009:adverse effects; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced
D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D010743:Phospholipids; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D011727:Pyridinolcarbamate; D002994:Clofibrate
Effetti indesiderati dei farmaci ipolipidemizzanti.